- 現金殖利率: 1.08%、總殖利率: 1.08%、5年平均現金配發率: 50.75%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 3.14 | -34.03 | 1.60 | -36.0 | 0.00 | 0 | 50.96 | -2.98 | 0.00 | 0 | 50.96 | -2.98 |
| 2024 (4) | 4.76 | 34.46 | 2.50 | 25.0 | 0.00 | 0 | 52.52 | -7.04 | 0.00 | 0 | 52.52 | -7.04 |
| 2023 (3) | 3.54 | -43.45 | 2.00 | -33.33 | 0.00 | 0 | 56.50 | 17.89 | 0.00 | 0 | 56.50 | 17.89 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 1.45 | 43.56 | 23.93 | 1.26 | 85.29 | 9.57 | 1.45 | -53.97 | 23.93 |
| 25Q4 (7) | 1.01 | 8.6 | -14.41 | 0.68 | 15.25 | -33.98 | 3.15 | 47.2 | -34.24 |
| 25Q3 (6) | 0.93 | 2225.0 | 14.81 | 0.59 | -30.59 | -45.87 | 2.14 | 76.86 | -40.56 |
| 25Q2 (5) | 0.04 | -96.58 | -97.16 | 0.85 | -26.09 | -29.75 | 1.21 | 3.42 | -56.63 |
| 25Q1 (4) | 1.17 | -0.85 | 0.0 | 1.15 | 11.65 | 0.0 | 1.17 | -75.57 | 0.0 |
| 24Q4 (3) | 1.18 | 45.68 | 0.0 | 1.03 | -5.5 | 0.0 | 4.79 | 33.06 | 0.0 |
| 24Q3 (2) | 0.81 | -42.55 | 0.0 | 1.09 | -9.92 | 0.0 | 3.60 | 29.03 | 0.0 |
| 24Q2 (1) | 1.41 | 0.0 | 0.0 | 1.21 | 0.0 | 0.0 | 2.79 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 1.61 | -19.89 | 13.83 | 6.6 | 26.66 | 4.89 | N/A | - | ||
| 2026/3 | 2.01 | 58.37 | 74.15 | 4.99 | 31.45 | 4.99 | 1.0 | 115年3月月營收較去年同期增加達50%以上，主係本公司光引發劑、抗氧化劑、紫外光吸收劑及光安定劑銷售皆較去年同期增加 | ||
| 2026/2 | 1.27 | -25.81 | 2.77 | 2.98 | 12.79 | 4.74 | 1.05 | - | ||
| 2026/1 | 1.71 | -2.7 | 21.59 | 1.71 | 21.59 | 5.1 | 0.98 | - | ||
| 2025/12 | 1.76 | 7.64 | 22.59 | 17.11 | 16.18 | 4.6 | 1.09 | - | ||
| 2025/11 | 1.63 | 35.1 | 43.15 | 15.35 | 15.49 | 4.61 | 1.09 | - | ||
| 2025/10 | 1.21 | -31.45 | 9.15 | 13.72 | 12.89 | 4.81 | 1.04 | - | ||
| 2025/9 | 1.76 | -3.89 | 47.15 | 12.51 | 13.27 | 4.88 | 0.97 | - | ||
| 2025/8 | 1.84 | 43.02 | 35.53 | 10.74 | 9.14 | 4.2 | 1.13 | - | ||
| 2025/7 | 1.28 | 18.93 | 11.04 | 8.91 | 4.93 | 3.69 | 1.29 | - | ||
| 2025/6 | 1.08 | -18.88 | -13.85 | 7.62 | 3.96 | 3.82 | 1.21 | - | ||
| 2025/5 | 1.33 | -5.95 | 5.25 | 6.54 | 7.64 | 3.9 | 1.19 | - | ||
| 2025/4 | 1.41 | 22.54 | 5.29 | 5.21 | 8.27 | 3.8 | 1.22 | - | ||
| 2025/3 | 1.15 | -6.53 | -20.49 | 3.8 | 9.42 | 3.8 | 1.26 | - | ||
| 2025/2 | 1.24 | -12.23 | 26.71 | 2.64 | 30.95 | 4.08 | 1.18 | - | ||
| 2025/1 | 1.41 | -1.9 | 34.91 | 1.41 | 34.91 | 3.98 | 1.2 | - | ||
| 2024/12 | 1.43 | 25.69 | 32.42 | 14.73 | 16.63 | 3.68 | 1.29 | - | ||
| 2024/11 | 1.14 | 3.02 | 1.07 | 13.29 | 15.15 | 3.45 | 1.38 | - | ||
| 2024/10 | 1.11 | -7.59 | 9.27 | 12.15 | 16.68 | 3.66 | 1.3 | - | ||
| 2024/9 | 1.2 | -11.48 | 2.64 | 11.04 | 17.48 | 3.71 | 1.26 | - | ||
| 2024/8 | 1.35 | 17.18 | 47.17 | 9.84 | 19.58 | 3.76 | 1.24 | - | ||
| 2024/7 | 1.16 | -7.73 | 3.87 | 8.49 | 16.11 | 3.67 | 1.27 | - | ||
| 2024/6 | 1.25 | -0.89 | 7.03 | 7.33 | 18.31 | 3.86 | 1.21 | - | ||
| 2024/5 | 1.26 | -5.92 | 8.31 | 6.08 | 20.93 | 4.06 | 1.15 | - | ||
| 2024/4 | 1.34 | -7.46 | 52.22 | 4.81 | 24.75 | 3.77 | 1.24 | 子公司業績成長，故使本月營收增加 | ||
| 2024/3 | 1.45 | 48.96 | 44.39 | 3.47 | 16.6 | 3.47 | N/A | - | ||
| 2024/2 | 0.97 | -6.55 | -1.76 | 2.02 | 2.42 | 3.1 | N/A | - | ||
| 2024/1 | 1.04 | -3.71 | 6.67 | 1.04 | 6.67 | 3.26 | N/A | - | ||
| 2023/12 | 1.08 | -4.05 | -3.41 | 12.62 | -20.98 | 3.23 | N/A | - | ||
| 2023/11 | 1.13 | 11.37 | 0.0 | 11.54 | -22.3 | 3.31 | N/A | - | ||
| 2023/10 | 1.01 | -13.2 | -8.37 | 10.41 | -24.14 | 3.1 | N/A | - | ||
| 2023/9 | 1.17 | 26.91 | -4.47 | 9.4 | -25.52 | 3.2 | N/A | - | ||
| 2023/8 | 0.92 | -17.29 | -26.09 | 8.23 | -27.78 | 3.2 | N/A | - | ||
| 2023/7 | 1.11 | -4.92 | -23.25 | 7.31 | -27.99 | 3.45 | N/A | - | ||
| 2023/6 | 1.17 | 0.29 | -17.75 | 6.2 | -28.78 | 3.22 | N/A | - | ||
| 2023/5 | 1.17 | 32.21 | -24.31 | 5.03 | -30.94 | 3.06 | N/A | - | ||
| 2023/4 | 0.88 | -12.22 | -41.38 | 3.86 | -32.72 | 2.88 | N/A | - | ||
| 2023/3 | 1.01 | 1.34 | -34.8 | 2.98 | -29.63 | 2.98 | N/A | - | ||
| 2023/2 | 0.99 | 1.48 | -2.25 | 1.97 | -26.67 | 3.09 | N/A | - | ||
| 2023/1 | 0.98 | -12.82 | -41.5 | 0.98 | -41.5 | 3.23 | N/A | - | ||
| 2022/12 | 1.12 | -0.66 | -13.1 | 15.98 | 7.15 | 3.36 | N/A | - | ||
| 2022/11 | 1.13 | 2.05 | -11.76 | 14.86 | 9.07 | 3.46 | N/A | - | ||
| 2022/10 | 1.11 | -9.51 | -12.16 | 13.73 | 11.24 | 3.58 | N/A | - | ||
| 2022/9 | 1.22 | -1.8 | -22.41 | 12.62 | 13.9 | 3.92 | N/A | - | ||
| 2022/8 | 1.25 | -14.1 | 18.65 | 11.4 | 19.93 | 4.12 | N/A | - | ||
| 2022/7 | 1.45 | 1.88 | 43.9 | 10.15 | 20.08 | 4.42 | N/A | - | ||
| 2022/6 | 1.42 | -7.7 | -2.4 | 8.7 | 16.86 | 4.47 | N/A | - | ||
| 2022/5 | 1.54 | 2.4 | 16.6 | 7.28 | 21.55 | 4.59 | N/A | - | ||
| 2022/4 | 1.51 | -2.38 | 31.42 | 5.74 | 22.96 | 4.06 | N/A | - | ||
| 2022/3 | 1.54 | 51.94 | 6.57 | 4.23 | 20.2 | 4.23 | N/A | - | ||
| 2022/2 | 1.02 | -39.26 | 7.04 | 2.69 | 29.73 | 3.98 | N/A | - | ||
| 2022/1 | 1.67 | 29.48 | 48.9 | 1.67 | 48.9 | 4.24 | N/A | - | ||
| 2021/12 | 1.29 | 0.86 | 8.11 | 14.91 | 28.57 | 3.83 | N/A | - | ||
| 2021/11 | 1.28 | 1.58 | 22.56 | 13.62 | 30.92 | 4.12 | N/A | - | ||
| 2021/10 | 1.26 | -20.07 | 47.52 | 12.34 | 31.85 | 3.89 | N/A | - | ||
| 2021/9 | 1.58 | 50.18 | 80.0 | 11.08 | 30.27 | 3.63 | N/A | 因去年基期過低,致本期營收變動幅度超過50% | ||
| 2021/8 | 1.05 | 4.16 | 24.96 | 9.5 | 24.56 | 3.52 | N/A | - | ||
| 2021/7 | 1.01 | -30.9 | 8.34 | 8.45 | 24.52 | 3.79 | N/A | - | ||
| 2021/6 | 1.46 | 10.27 | 48.05 | 7.45 | 27.08 | 0.0 | N/A | - | ||
| 2021/5 | 1.32 | 15.41 | 44.72 | 5.99 | 22.85 | 0.0 | N/A | - |